Ocugen (OCGN) EBIT Margin (2020 - 2026)
Ocugen's EBIT Margin was -1105.11% in Q2 2026, down 100.37 percentage points from -1004.73% a year earlier but up 58.56 percentage points from the prior quarter.
Powered by 
Analysis
Ocugen (OCGN) EBIT Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ocugen's EBIT Margin was -1504.43% through Jun 30, 2026, down 339.35 percentage points year-over-year; for FY2025, it was -1425.70%, down 75.34 percentage points from FY2024.
- EBIT Margin shows a five-year change of +48074.30 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was -1350.36% in FY2024 (-264.69 pp), -1085.67% in FY2023 (+2494.35 pp) and -3580.02% in FY2022.
- Quarterly EBIT Margin has moved between -5388.41% (Q3 2022) and -336.06% (Q3 2023) over five years.
- Compared with a year earlier, EBIT Margin was higher in three of the last seven quarters, with an average year-over-year change of -196.22 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q3 2023 (a gain of 5052.35 percentage points); the worst was Q2 2023 (a drop of 1498.09 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.17 Bn | 1,102.76 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 615.84 Bn | 534.36 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 500.69 Bn | 473.80 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 367.34 Bn | 321.72 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 297.61 Bn | 261.60 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.07 Bn | 234.75 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 235.51 Bn | 190.91 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 190.60 Bn | 164.80 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 169.37 Bn | 116.02 Bn | 10.94 Bn | 28.37% |
| 10 | Ocugen | 274.09 Mn | 90.61 Mn | - | -1,105.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,105.11% |
| Mar 31, 2026 | -1,163.67% |
| Sep 30, 2025 | -1,005.99% |
| Jun 30, 2025 | -1,004.73% |
| Mar 31, 2025 | -979.14% |
| Dec 31, 2024 | -1,811.52% |
| Sep 30, 2024 | -1,166.55% |
| Jun 30, 2024 | -1,353.99% |
| Mar 31, 2024 | -1,204.73% |
| Dec 31, 2023 | -817.96% |
| Sep 30, 2023 | -336.06% |
| Jun 30, 2023 | -4,853.61% |
| Mar 31, 2023 | -4,071.11% |
| Dec 31, 2022 | -2,657.00% |
| Sep 30, 2022 | -5,388.41% |
| Jun 30, 2022 | -3,355.52% |
| Mar 31, 2022 | -3,806.00% |
| Jun 30, 2020 | -7,827.91% |
API Access
Ocugen EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=OCGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "OCGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=OCGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();